Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

ISPOR partner seal

Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...

Genesis Research Group

- PMLiVE

Map the Patient Journey Virtually – Engaging Your Advisors Creatively

Improve patient experiences! Learn how to co-create patient journey maps with your advisors virtually, identify healthcare gaps, and streamline care pathways.

Impetus Digital

Woman working at laptop

How is generative AI transforming clinical trials?

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.

Cuttsy + Cuttsy

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Datroway approved by EC to treat breast cancer

Approximately 557,000 people are diagnosed with breast cancer every year in Europe

- PMLiVE

Sanofi’s tolebrutinib shown to delay MS disability progression in phase 3 study

The BTK inhibitor has been granted FDA priority review to treat the neurodegenerative disease

- PMLiVE

Compass Therapeutics’ tovecimig shows promise in phase 2/3 biliary tract cancer study

Around 23,000 cases of the aggressive cancer are diagnosed in the US every year

- PMLiVE

BMS granted FDA approval for immunotherapy combination in colorectal cancer

More than 154,000 cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

AbbVie’s Rinvoq receives EC approval to treat adults with giant cell arteritis

The drug is now the first oral JAK inhibitor to be approved in the EU for this patient population

- PMLiVE

Johnson & Johnson shares positive late-stage results for Tremfya in psoriatic arthritis

The inflammatory condition affects approximately 30% of psoriasis patients

- PMLiVE

Collaboration Across Healthcare is the Path Forward

How do we impress upon women that they need to prioritize their own health before providing for the people who need them? A leader in medical oncology has a few...

Medscape Education

- PMLiVE

Eli Lilly and Sangamo Therapeutics enter CNS disease partnership worth over $1.4bn

The deal gives Lilly access to Sangamo’s neurotropic adeno-associated virus capsid

- PMLiVE

Ipsen’s Iqirvo accepted by SMC to treat rare liver disease primary biliary cholangitis

The life-long condition affects approximately 1,900 people in Scotland

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links